1. Home
  2. PROF vs SSSS Comparison

PROF vs SSSS Comparison

Compare PROF & SSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$6.97

Market Cap

238.1M

Sector

Health Care

ML Signal

HOLD

Logo SuRo Capital Corp.

SSSS

SuRo Capital Corp.

HOLD

Current Price

$13.56

Market Cap

233.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PROF
SSSS
Founded
N/A
2010
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
238.1M
233.4M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
PROF
SSSS
Price
$6.97
$13.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$12.00
$15.67
AVG Volume (30 Days)
83.4K
391.8K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
7.61%
EPS Growth
25.89
N/A
EPS
1.41
N/A
Revenue
$16,098,000.00
N/A
Revenue This Year
$92.40
N/A
Revenue Next Year
$64.10
$42.86
P/E Ratio
$4.83
$3.61
Revenue Growth
50.73
N/A
52 Week Low
$3.92
$4.90
52 Week High
$8.95
$13.66

Technical Indicators

Market Signals
Indicator
PROF
SSSS
Relative Strength Index (RSI) 56.97 67.37
Support Level $5.75 $8.51
Resistance Level $7.07 $13.66
Average True Range (ATR) 0.40 0.40
MACD 0.01 -0.05
Stochastic Oscillator 74.07 91.54

Price Performance

Historical Comparison
PROF
SSSS

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

About SSSS SuRo Capital Corp.

SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.

Share on Social Networks: